SPRINGFIELD, Va., Aug. 1, 2013 /PRNewswire/ -- Versar, Inc. (NYSE MKT: VSR) announced today that it has received a 5-year, $4.8 million contract awarded by the U.S. Environmental Protection Agency (EPA) Office of Water to conduct scientific peer reviews of EPA documents, assessments, and tools to ensure that major scientific products receive critical review prior to dissemination or use by EPA. A broad range of water-related topics may be subject to peer review, including: human health and ecological criteria, health advisories, engineering analyses, and remediation strategies. This contract continues Versar's 30 years of support to the EPA Office of Water.
In the past 12 months, Versar has won contracts with EPA's Office of Research and Development and with the US Food and Drug Administration (FDA); this award is the third peer review contract win. Versar is providing similar peer review support under the other two contracts, assembling expert panels to review EPA's and FDA's scientific products. Other support includes organizing meetings and workshops, preparing risk assessments, conducting literature reviews, and other technical and scientific assistance.
Mr. Jeff Moran, Senior Vice President Environmental Services of Versar, said, "We are very pleased to have been selected for another peer review contract supporting a major Federal agency. EPA and FDA continue to rely on Versar to ensure the quality of major scientific and technical products. We look forward to supporting EPA and FDA these next five years with their peer review needs through these three contracts."
VERSAR, INC., headquartered in Springfield, VA, is a publicly traded global project management company providing sustainable value oriented solutions to government and commercial clients in the construction management, environmental services, munitions response, and telecommunication and technology integration market areas.
This news release contains forward-looking information. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be significantly impacted by certain risks and uncertainties described herein and in Versar's Annual Report on Form 10-K filed with the Securities and Exchange Commission for the fiscal year ended June 29, 2012, as updated from time to time in the Company's periodic filings. The forward-looking statements are made as of the date hereof and Versar does not undertake to update its forward-looking statements.
SOURCE Versar, Inc.